Embrace the Journey of Change
December 3, 2024
Read more
Spravato® (Esketamine) is an FDA-approved nasal spray that is a rapid-acting antidepressant for the treatment of depression.
Get Appointment
If you’ve been battling depression that doesn’t respond to multiple oral antidepressants, Spravato® might be the answer. Specifically designed for adults with Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), or suicidal thoughts. Adding Spravato® to your current treatment plan could bring the relief you’ve been searching for. Speak with your healthcare provider to explore if this innovative therapy is right for your needs. Above all it's covered by insurance at Penfield Psychiatry.
Request AppointmentSpravato® (Esketamine) is a nasal spray medication endorsed by the U.S. Food and Drug Administration (FDA), specifically designed to treat adults with Treatment-Resistant Depression (TRD) and depressive symptoms in Major Depressive Disorder (MDD) with suicidal thoughts. Unlike traditional oral antidepressants, Spravato® works rapidly, targeting specific brain receptors to restore chemical imbalances, providing relief for those who have not responded to other treatments.
Administered under the supervision of a healthcare provider, Spravato® is part of a comprehensive treatment plan that includes an oral antidepressant. It offers a new approach to managing severe depression symptoms effectively.
Before starting Spravato®, it’s crucial to understand its benefits, risks, and suitability for your health needs. Consult with your healthcare provider to determine if it’s right for you.
At Penfield Psychiatry, we’re committed to making mental health care accessible and affordable. That’s why we partner with a wide range of insurance providers to ensure seamless coverage for our patients.
.png)
-Logo.wine.png){kind=logo}
